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ABSTRACT 
Objective:  To know functional outcome of microvascular decompression in trigeminal neuralgia. 
Materials and Methods:  This prospective study was conducted in the Department of Neurosurgery Lady Reading 
Hospital Peshawar from July 2014 to Dec. 2017. Patients with idiopathic trigeminal neuralgia with failed 
medical treatment were included in this study. A Barrow Neurological Institute pain score was calculated for all 
patients’ pre and post operatively. Microvascular decompression was done in all cases and follow up done in the 
outpatient department of all operated cases. 
Results:  Thirty six patients were included in the study and operated for trigeminal neuralgia. Pre-operatively 20 
(55.5%) patients had a score of 5 and 16 (44.4%) had a score of 4. Postoperatively, at the last clinic follow up, 18 
patients (48.6%) had a score of 1 while 15 (37.8%) had a score of 3 and 3 (8.1%) had a score of 4. Complication 
developed in nine cases which included cerebrospinal fluid leak (3 patients), 1 patient hearing loss, 2 patients 
developed wound infection, 1 patient meningitis and cerebellar hematoma in 1 patient. 
Conclusion:  Good preoperative workup in the form of history, physical examination, radiological workup and 
microsurgical techniques are pivotal for a successful outcome. Microvascular decompression is currently a safe 
and effective treatment option for patients having trigeminal neuralgia not responding to medical management. 
Abbreviations:  BNIP:  Borrow Neurological Institute Pain Scale. TN: Trigeminal Neuralgia. TNS: Trigeminal 
Nerve System. MVD: Microvascular Decompression. CSF: Cerebrospinal Fluid. 
Keywords:  Trigeminal neuralgia, Microvascular decompression, Borrow neurological institute pain scale. 
 
INTRODUCTION 
Trigeminal neuralgia (TN) is well known disease for 
the physicians since ancient times. Aretaeus of 
Cappadocia described one sided facial pain causing 
spasmodic facial contraction in the 2nd century A.D. 
An Arab physician Jujani also mentioned Trigeminal 
neuralgia in the 11th century A.D. Typical symptoms 
of TN was described by John Fothergill in 1773.
1
 
Episodic nature of symptoms and its association with 
certain activities like tactile pressure, chewing, 
brushing, breeze of air, or speaking was noted by 
Fothergill. The term “tic douloureux” was used for the 
first time by the French surgeon Nicholas André in 
1756.
2
 Trigeminal neuralgia has fascinated an 
extensive cohort of scientists, including but not limited 
to pathologist, dentists, neurologists, neurosurgeons, 
physicians, ophthalmologist and psychiatrists. The 
etiological myth of TN still remains controversial. 
Contemporary popular theories are based on three 
main etiologic causes. The first theory is based on 
organic causes leading to TN due vascular pathologies, 
multiple sclerosis, diabetes mellitus, rheumatism and 
others. Direct injury to peripheral or central portion of 
the trigeminal nerve may be one of the inciting causes 
of the disease by some researchers. A third hypothesis 
stress more on the polyetiologic origin of the disease 
resulting in demyelination and atrophy of the nerve.
3
 
 Scientific evidence to support each hypothesis is 
lacking and in most of the cases, no cause can be 
found. Patients with TN also suffer from other 
vascular pathologies like atherosclerosis and scientists 
also found changes in blood rheology in these blood 
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vessels which supplies the trigeminal nerve system 
(TNS). Scientific evidence for such hypothesis is 
lacking.
3
 However, these changes in the blood vessels 
do influence the disease. Multiple sclerosis (MS) is 
also linked with the etiology of TN. Only a small 
percentage of MS patients suffer from TN (0.9% to 
4.5%) and TN may be the first manifestation of MS in 
9% – 14% patients.4-6 
 






1. Electric shock like 
sharp,episodic pain with clear 
pain free interval 
2. Pain which is throbbing, 
aching and  burning,  with a 
background constant pain 
>50% of time 
Trigeminal injury 
1. Nerve injury due to trauma, 
skull base surgery 
(unintentional injury) 
2. Intentional (neurectomy, 
gangliolysis, rhizotomy etc.) 
 Associated with MS 
 Nerve involvement due to 
herpes zoster 















Atypical facial pain 
 
MATERIAL AND METHODS 
Study Design 
Descriptive case series. 
Approval for this study was taken from the hospital 
ethical committee. This descriptive study was done in 
the Department of neurosurgery lady reading hospital 




All patients of idiopathic trigeminal neuralgia with 
failed medical therapy were included in this study. 
Informed consent was taken from all patients. 
 
Exclusion Criteria 
Preoperative workup included detail history, a 
comprehensive general and neurological examination 
and MRI of the brain with and without contrast. 
Patients having a TN due tumor in the 
cerebellopontine angle, MS, those with nerve injury 
due to trauma or surgery, those whose disease was 
controlled on pharmacological treatment or those 
refusing surgery were excluded from the study. 
 
Data Collection Procedure 
All data was collected by its entry on special design 
performa. 
 Patients were assessed post operatively by Borrow 
neurological institute pain scale (BNIP scale for pain 
relief (Table 2) and findings were documented on 
predesigned Pro forma. A patient whose disease was 
refractory to surgery was put again on drug treatment. 
 
Table 2: Borrow neurological institute pain scale 
(BNIP). 
 
Score Pain description 
I 
No clinical evidence of disease, no medication 
required 
II Occasional pain, no medication required 
III 
Patient takes medications for pain and symptom 
controlled by medications. 
IV 
Patient have pain and is  not  controlled by 
medication 
V 
Patient is having no relief from pain and still 
suffers excruciating pain.  
 
Surgical Technique 
The patient is positioned in the lateral (park bench) 
position, and the head tilted 10 degrees toward the 
floor for better visualization of the trigeminal nerve. A 
small linear (3-5 cm) incision is given 1 cm behind the 
mastoid groove, dissection carried out until asterion 
identified. A small (2x3cm) retromastoid craniectomy 
is done exposing the sigmoid and transverse sinus 
junction. The dura is opened in a “Y” shaped and 
anchored to the wound edges. Cerebrospinal fluid is 
released to allow the cerebellum to fall back. The 
angle between tentorium and the petrous bone is 
followed till the trigeminal nerve is identified. 
Arachnoid dissection is done sharply around the 
trigeminal nerve from pons to the Meckel's cave. The 
offending vessel is found in more than 90% of cases. 
All offending vessels are sharply dissected and nerve 
totally freed from the conflict. A Teflon nonabsorbable 
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or absorbable oxidized cellulose or muscle patch, then 
interposed between the nerve and vessel. Most 




Data was analyzed by SPSS version 20 and 
represented in the form of tables, graphs and charts. 
Post operatively patients were assessed by BNIP after 




Total 36 patients underwent MVD for trigeminal 
neuralgia from July 2014 to Dec 2017 (42 months) 
including 21 females and 15 males (Table 3). 
 
Table 3:  Sex Incidence. 
 
Sex N % Accumulative % 
Male 15   42%   42% 
Female 21   58% 100% 
Total 36 100% 100% 
 
Age Incidence 
Age incidence mean age of 51 years (range 31-64). 
 
Outcome 
All diagnosed patients with failed medical therapy 
underwent microvascular decompression (MVD). A 
Barrow Neurological Institute pain score was 
calculated for all patients (Table 2). Pre-operatively 20 
(55.5%) patients had a score of 5, 16 (44.4%) had a 
score of 4 (Table 4). Postoperatively, at the last clinic 
follow up, 18 patients (48.6%) had a score of 1 while 
15 (77.8%) had a score of 3 and 3 (8.1%) had a score 
of 4 (Table 5). A post-operative score of ≤ 3 was 
considered a satisfactory outcome. 
 
Table 4:  Pre-operative BNIP Score. 
 
Score N % 
Accumulative 
% 
4 20   56%   56% 
5 16   44% 100% 
Total 36 100% 100% 
Table 5:  Post-operative BNIP Score. 
 
Score N % 
Accumulative 
% 
1 18   50%   56% 
3 15   41%   91.6% 
4   3     8.4% 100% 
Total 36 100% 100% 
 
Complications 
Nine patients developed post-operative complications, 
3 developed cerebrospinal fluid leak, 1 patient hearing 
loss, 2 patients developed wound infection, 1 patient 
meningitis and cerebellar hematoma in 1 patient. 
 CSF leak in all 3 patients was managed 
conservatively with bed rest, reinforcement sutures, 
stool softener and lumber drain in 1 patient. Wound 
infection and meningitis were treated with antibiotics 
and cerebellar hematoma also subsided with 
conservative measures. Postoperative complications 
are mentioned in Table 6. 
 
Table 6:  Postoperative complications. 
 
Complications No of Patient Percentage % 
CSF Leak 3 8.34 
Wound infection 2 5.4 
Meningitis 0 0 
Hearing Loss 1 2.8 
Facial Nerve palsy 1 2.8 
Post Fossa hematoma 1 2.8 
Facial sensory loss 
(S&N) 
0 0 
vertigo 1 2.8 
Mortality 0 0 
 
 Facial weakness also improved with physiotherapy 
at last follow up (6 months). 
 
DISCUSSION 
Microvascular decompression (MVD) of the 
trigeminal nerve is undertaken through retro-sigmoid 
craniectomy in those patients who were unable to 
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tolerate the drugs due to the adverse effects or due to 
failure of drug treatment to control the pain. All 
patients were screened with an MRI pre-operatively to 
rule out other pathological entities like mass lesion or 
demyelination and to look for any flow void (vessels) 
in the vicinity of the trigeminal nerve. Vascular loop 
compressing the trigeminal nerve have better 
functional outcomes after MVD. Postoperative hearing 
loss with a reported incidence of 1-1.4% due to close 
relation of VIII to trigeminal nerve has been reported 
in the literature.
7,9
 Complications of MVD include, but 
not limited to facial palsy, sensory loss, postoperative 
hematoma, CSF leak, wound infection and meningitis. 
In our study, with an average of 9 month post-
operative follow up, 33 patients (76%) had a good 
functional outcome (Barrow score ≤ 3), while 3 (24%) 
reported an unsatisfactory outcome. 
 A large study by Barker et al which included a 
cohort of 1185 patients who received treatment in the 
form of MVD over a 19-year period reported the same 
results and findings. Barker reported that 75% of 
patients were completely pain free after MVD, with a 
further 9% reporting a partial response. Ten years 
postoperatively, 64% of patients reported complete 
relief, and 4% reported partial relief.
9
 A study in 2010 
by Sarsam et al which included 372 patients treated 
with MVD between 1982 and 2005 for TN with failed 
medical therapy reported that 84% of patients were 
pain-free, without the need for medication, at one year, 
and that 71% were pain-free without the need for 
medication at 10 years post-operatively.
10
 
 Present safe general anesthesia, micro 
neurosurgical techniques, availability of 
neuronavigation, and per operative neuromonitoring 
can further reduce the problems in microvascular 
decompression surgery.
11
 In our series, we observed 
no mortality or vascular complication in form of 
intracranial bleed or ischemic event. Neurologic deficit 
manifested as hearing loss in 1 patient and mild facial 
weakness (House-Brackmann grade II) in 1 patient, 
which recovered completely till last the follow-up (6 
month). In a large series by Jannetta also founder and 
advocate for MVD reported a mortality of 0.3% (2 
cases) out of 618 cases in the micro vascular 
decompression surgery and a recurrence rate of about 
25% at 4 year follow-up.
12
 
 Due to the readiness of diagnosis, availability of 
good quality images, safe general anesthesia and 
refinement in microsurgical techniques MVD is now 
the treatment of choice for trigeminal neuralgia in 
those patients having failed medical treatment.
13,14
 
With the resurgence of neuroendoscopy endoscopic 
MVD is revolving quickly with results comparable to 
open surgery.
16
 For cases refractory to medical 
management or those after failure of MVD other less 
invasive treatment options are available most of these 
options are ablative but should always be considered 
in patients having the co morbid condition precluding 
general anesthesia or those having limited life 
expectancy. Various other less invasive ablative 
procedures like radiofrequency thermocoagulation, 
glycerol rhizolysis, percutaneous microcompression 
(balloon microcompression) and stereotactic 
radiosurgery should always be considered in the 
elderly and those with co morbid.
17
 
 These ablative but less invasive procedures carry 
inherent risk of any facial sensory loss (numbness) 
which may be annoying for some patients. Recurrence 
is more common with these when compared to MVD. 
Abdennebi et al in his retrospective large study of 901 
which were treated with balloon micro-compression 
reported pain relief without the need for medication in 
67% of patients at one year follow-up which reduced 
to 48% at 16 year follow-up.
18
 
 Stereotactic radiosurgery (SRS) use is increasing 
because of its least invasive nature in treatment of TN. 
Using neuronavigation platform highly targeted 
radiation is delivered to the trigeminal nerve root entry 
zone. The success rate in term of pain relief is much 
lower than the MVD with a rate of 51.5% at ten years, 
followed up has been reported in a recent literature
19
. 
Onset of action of the SRS is delayed during which 
time patient will be on medication as compared to 
other treatment modalities where pain relief is 
immediate. However, it is still a good option for some 






In conclusion, microvascular decompression is an 
established safe surgical procedure in patients who 
disease is resistant to drug treatment or when patient 
unable to continue drug treatment due to its toxic side 
effects. However, the rates of post-operative pain 
reduction in patients undergoing this operation in our 
center are not at par with the international literature 
due to the small size of the study. However, this may 
be also due to a large proportion of patients with 
negative prognostic factors pre-operatively (e.g., long 
duration of TN prior to operation), or due to 
discrepancy in outcome measurement. Neurologists 
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and other physicians involved in the management of 
TN should consider referral to a neurosurgical unit 
following the failure of medical therapy. 
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